Page:United States Statutes at Large Volume 113 Part 3.djvu/594

This page needs to be proofread.


113 STAT. 2112 PROCLAMATION 7207—JULY 1, 1999 Annex (con.) -6- Section A. (con.) 2. (con.) (c). (con.) Pro d uct CAS Number acstamlde hydrochloride dit«niyll-(2,4KJifluoro(Jh«nyl)-2 -(1H-1.2,4.iriazol-1-yl)-1-(iH-1.2,4-tria20l-1-ylmethyl)«thyl phosphate (S)-2-^3^(2-(luorob•nzyl)»ulfonylalninol-2-oxo-2,3-dihyd^o-1-pyridyl)-N -(1-fo^myl- 4 -guanidlnobutyl)acatatTiide 4-[4-(434-{(3R,5R)-S-(!i.4 -di(lucrophenyl)-5 -(1H-1,2,4-tna20l-1 -ylmelhyljtetrahydrofuran- 3-yirnethyloxy]phenyl)piperazin-1-yl)phenyq-1-[(1S,2S)-1-«thyl-2-hydroxypropyl]- 'tetrahydroqulnazolin-1-yll acetate 193275-84-2 193275-85 -3 137 246 -21 -0 142 034 -92 -2 21472-89-9 112 733 -28 -5 92050-02 -7 186 038 -82- 4 556-90-1 1620-98-0 2,6-diisopropylphenyl sulfamate diethyl (1-cyano-3-methylbutyl)nnalonate 2-iniino-1.3-thia2ol-4-or» 3,5.drle(t-butyM-hydroxybenzaldehyde N-(blp h enyl -2-yl)-4-l(2-n r ieth yl-4,5-d ih xd ro -1H -ir ni daz o [4,5-d][1)benz az epi(i-6 -yl)c3rb oi iyl]ben z arn id d 795 28 -39 -3 3-(ami no n ieth yl> -5-meth yl h«x ano ic acid 12 8013-69 -4 .\ .... .. ,. 4276-85 -1 182 149 -25 -3 142034-97-7 70890-50-5 1 291 40- 12-1 59032-27-8 183319-69 -9 so di um 1,2, 3-t(taz ol e-5-th k> ute (3-e t)!yny lp he nyl){6,7-b it(2 -in eth oxye tho xy)qui n azo l in -' H(1S,2S)-2-hydroxy-2-<44i¥droxyphenyl)-1-methylethj 4-ol mathanesulfonafetnnydrate ,. . , nyta „, ri R,4S)-1 -azabkyclori.2.1]heptan-^ne 3-a ni ln o- 7-iT iet hyt-5-p n en y(-1H -1,4-b en 2o dl aze pi n-2 (3H)-o n e 1-ethyl-l,4-diphenylbul-3-enylamlne sodium 1,2,3-triazole-5 -thiolate ')quinazolin-4 -yl1amine hxdrochloride l-methylethylH-phenylpiperldintiydra'te (5R6S)-6-phenyl-5-L4-(2-pyrrolidinoethoxy)phenyl]-5,6,7,8-tetrahydro-2-naphthol- (•) -tar tari c add (1: 1) 1-[(S)-3-<acelylthio)-2-methylpropionyl]-L -proline 4'-Mnzytoxy-2-[(1-niethyl-2-phenoxyeihyl)amlno]propiophenone hydrochloride 5-(3-d i methy lami n op ro py l)-10, 11-d lhydr o diben z o[a, djcycl oh ep ten-5-o l 2-aminoethyldiethyramine lsopropyl(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3R)-3-hydroxy- 4-[3-(tn flu o ro mel hyl)phen o xy]bu t-1-en yl}-cy clo pe ntyq h epl -5-en oa te 21-benzyloxy-9-alpha-nuoro-11 -beta, 17-arpna-dihydroxy-16-alph8-methylpresna-1,4 -diene- 3,20-dione pilocarpine atropine 4-niirobenzyl(4R,5R,6S)-3-(dlphenoxyphosphoiyloxy)-6-{(R)-1-hydroxyethyl]-4-inethyl-7-oxo- 1-azabicyclo(3.2.01hept-2-«ne-2 -cafboxy1ate 2-aminoprop8na-1,3-dlol methyl 4-(bromomethyl)benzoate 2-bu tyl im id azo l a-5-cai b ald eh yde ethyl nydrogen (2-thlenylmethyl)malonale 4-{2-butyt-5-formylimidazol-1-ylme(hyl)benzo<c acid 2,6-dicNore-4-fKethylnlcotinonitrile 3,5-diacetamido-2,4,6-triiodobenzoic acid dihydrate 2.2,2-trtlluoroethano) 13-«thyl-17-alpha-hydroxy-18.19-dinorpregn-4-en-20-yn-3-one oxime estropipate 1-0-(0-2-acetamido-2-deoxy-beia-D -galactopyranosyl-(1,4)-0-(N-acetyl-alphaneuraminosylH2,3)1-0-beta-0-galactopyranosyl-(1,4}-beta-D -glucqpyranose 1-(28-<0-0 -apio-beta-0-furano*yl-ri,3)-0-beta-D -xylopyranosyKi,4)-<>%-deoxy-alpha-L - mannopyranosyl>^1^)-4-0 -{5-^-alpha-l.-arablnofuranotyloxy-3-nydroxy-6 - methyk)ctanoyloxy)-3-nydroxy-6-rT)ethyloctanoyl)-6-deoxy-be(a-D -galac(opyranosyloxy}- 16-alpha-hydrox 1-0-(0-<N-acetyl-alpha-neuraminosyl)-(2,3)-0-[0-beta-0-galactopyranosyl-(1,3)-2-acetamido- 2-daoxy-bata-&4alactopyrano*yKl,4)]-0 -beta-D -galactopyrano*yl- (1^)-bata-0-glucqpyranotyl]ceramide 1-CKO-2-acetamido-2-deoxy-beta-{} -galactopyranosyH1,4)-0-(N-acetyl-alphaneuraminotyl>-(2,3)-0-bata-0-galaclopyranosyl-(l^)-beta-D -glucqpyranosyl]oeramide N-{I(1R,2R)-1-(OKN-ac8tyl-alpha-nauraminosyl)-(2,3)-0-2 -acetamido-2 -deoxy- oeta-O- galactopyianoayKI,4VO-beta-D^alaclopyranosy41 Ah beta-D -glucopyranotyloxymetnyl]-2-hydroxy-3-fonnylpropyl}stearamida fer ri stena codeine phosphatehemihydrate trans-1 -benzoyM-phenyl-C -proline 5-fflethyluridine hemihydrate 5'-t>enzoyl-2',3'-didehydro-3'-deoxythymidine 3',5'-anhydrathymidine 4'-<benzyioxycartx>nyn-4'-demethylepipodophyllotoxin 2,3,4,S-(etra-0 -benzyl-1-0 -(trimafnylsilyl)-b -D-glucose 2,3,4,6-tetra-0-benzyl-p -gluco«e 6-iodo-1 H-purin-2-ylamine '1R7R,3S)-2-amino-9.(2,3-bis(benzoyioxyniethypcyclobutyl]-9H-purin-6 -one 1RS,2RS,3SR)-2,3-bis(b«nzoyloxyfnathy1)cyclobufylamine 1RS,2RS.3RSJ-2.3-bis(benzayloxyfnat)<yl)cyclobutanol 1R,2R,3 S)-9-(2, 3-b ia(ben zo yl oxy metti yDcy dob utyl]-6-i od o -9H- pu ri n -2-yla min e 2S,3S)-2, 3-bi s(ben zo yl oxyn i eth yl)cy clo b utan o ne SV'5-(l,3-dioxolan-4-yl)-2-amlnovaleric add '!,N'-bls(tiilluoroacatyl)-OL-homocystine (S)-2-(acetylthio)-3:pnenylpropionic add-dicydohexylamine (1:1) methyl(4S,7S,10aS)-4 -amino-5-oxooctahydro-7H -pyridor2,1-b][1,3]thlazeplnc-7-caiboxylate 4'-(2-butyl-4-oxo-1,3-diazaspiro(4.41non-1-en-3-ylmethyl)biphenyl-2-carbonitrila DL-S-(1,2-dithiolan-3-yl)valeram1de 4-(4-meth o xyp hen yl)bu tan -2-o ne tetraisopropyl metnylenediphosphonate 'S)-1,2,3,4-tetrahydrolsoqulnoline-3-cart>oxyncacid S)-N -tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide hydrochloride S)-N -ter t-bu tyl-1,2, 3,4-tet rah yd ro iso q ui no li n e-3-car bo xami de su lf at e

3S)-tetrahydrofuran-3-yl (1S,2R)-3-{(4-aminophenylsulfonyl)(isobutyl)amino^1 -benzyl-

2-hydroxypropylcarbamate 6-b en zy l-1-(eth o xymath yl)-5-is op ro p ylpyr imi d in e-2, 4(1H,3H)-d io ne (2R, SS)-4-a min o -5-flu o ro -1-{2 -(hyd r oxym ethy n-1, 3-o xathi o lan -5-y(]pyr imi di n -2(1H)-ane 3'-az id o-2', 3'-d id eo xy-5-mctn yl cytid in e by d roc h lor ide 189894-57-3 19 079 1-2 9-6 64838-55-7 35205-50-6 1 159-03-1 100-36-7 1 57283-68-6 1 505 87- 07-8 92 -13 -7 51 -5 5-8 907 76- 59 -3 534 -03 -2 2417-72 -3 68282- 49 -5 14 3466-96 -6 152 146-59-3 875-35 -4 50978- 11 -5 75 -89 -8 53016-31- 2 7280-37-7 1 80200-68-4 7753-6<« 19 608 5-62 -8 155 773 -56 -1 41444-62-6 12 085 1-71 -0 25954-21 -6 122 567 -97 -9 38313-48-3 23363-33-9 80312-5 5-6 4132-28-9 196 90- 23-4 1561 26-53-3 15 180 7-5 3-3 12 775 9-90 -4 15 6126-89-3 13 229 4-16 -7 170 242 -34 -9 10 599 6-54 -1 15 752 1-26 -1 1673 04- 98- 5 13 840 1-24 -6 3206-73-3 104 -20 -1 166 0-95 -3 741 63 -81 -8 14 905 7-1 7-0 18 653 7-30 -4 16 181 4-49 -9 149 950 -60 -7 143 491 -57 -0 108 895 -45 -0